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Abstract.  The human asialoglycoprotein receptor sub- 
unit H2a is cotranslationally inserted into the ER 
membrane. When expressed together with subunit H1 
in mouse fibroblasts  part forms a hetero-oligomer that 
is transported to the cell surface, but when expressed 
alone it is all rapidly degraded. Degradation is insen- 
sitive to lysosomotropic agents and the undegraded pre- 
cursor is last detected in the ER region of the cell. 
Small amounts of an intermediate 35-kD degradation 
product can be detected (Amara, J. E, G. Lederkremer, 
and H. E  Lodish. 1989. J.  Cell Biol.  109:3315).  We 
show here that the oligosaccharides on both precursor 
H2a and the 35-kD fragment are Man6_9GlcNAc2, struc- 
tures typically found in pre-Golgi compartments. Sub- 
cellular fractionation shows that the intermediate 
degradation product does not cofractionate with the 
lysosomal enzyme ~-galactosidase, but is found in a 
part of the ER that contains ribosomes. Thus the inter- 
mediate degradation product is localized in the ER, in- 
dicating that the initial degradation event does take 
place in the ER. 
All degradation of H2a, including the initial endopro- 
teolytic cleavage generating the 35-kD intermediate, is 
blocked by the protease inhibitors N-tosyl-L-lysine chloro- 
methyl ketone and Notosyl-L-phenylalanine  chloromethyl 
ketone. These drugs do not inhibit ER-to-Golgi trans- 
port of HI. Depleting the cells of ATP or inhibiting pro- 
tein synthesis allows the initial endoproteolytic cleav- 
age to occur, but blocks further degradation of the 35-kD 
intermediate; thus we can convert all cellular H2 into 
the 35-kD intermediate. Approximately 50%  of H2b, a 
splicing variant differing from H2a by a five amino acid 
deletion, can be transported to the cell surface, and 
the rest appears to be degraded by the same pathway 
as H2a, both when expressed alone in fibroblasts  and 
together with H1  in HepG2 cells.  Addition of N-tosyl- 
L-lysine chloromethyl ketone or N-tosyl-L-phenylalanine 
chloromethyl ketone blocks degradation of the ~50% 
that is not transported, but does not affect the fraction 
of H2b that moves to the Golgi region. Thus, a protein 
destined for degradation will not be transported to the 
Golgi region if degradation is inhibited. 
C 
ELL surface molecules often exist as oligo- or multi- 
meric  complexes. The assembly of individual sub- 
units into complexes occurs in the ER and is in many 
cases a prerequisite for transport out of the ER (reviewed by 
Hurtley and Helenius,  1989). The oligomerization process 
can be viewed as a quality control step where aberrant or un- 
assembled polypeptides and incompletely assembled com- 
plexes are prevented from leaving the ER. The degradation 
of single subunits or incompletely assembled complexes has 
been described for the T cell receptor  (TCR)  t ~ and/3 sub- 
units (Lippincott-Schwartz et al., 1988) and the asialoglyco- 
protein receptor  H2 subunit (Amara et al.,  1989). In both 
instances the degradation was rapid, independent of lysoso- 
1. Abbreviations used in this paper: Endo D, endoglycosidase D; Endo H, 
endoglycosidase H;  E 64,  N-(N-[L-3-trans-carboxyoxiran-2-carbonyl]-L- 
leucyl)-agmatine; GlcNAc, N-acetyl-glucosamine; HMG CoA, 3-hydroxy- 
3-rnethylglutaryl coenzyme A;  man, mannose; TCR, T cell receptor. 
mal function, and insensitive to inhibitors of lysosomal pro- 
teases. Based on the findings that the intact precursor protein 
could last be detected in the ER by a variety of methods, it 
was suggested that degradation took place in or in close asso- 
ciation to the ER, and the term "ER-degradation" was coined. 
Here we show that indeed the ER is the site for initiation 
of degradation of unassembled subunits, using the asialogly- 
coprotein receptor as a model system. The functional human 
asialoglycoprotein receptor is composed of two homologous 
subunits, H1  and H2,  forming at least a trimer (H1)2(H2) 
(Bischoff et al., 1988). H1 and H2 are N-glycosylated pro- 
teins oriented in the ER membrane with their COOH-termi- 
nal domains in the ER lumen and the NH2 termini  in the 
cytoplasm. Both chains are needed to form a high-affinity re- 
ceptor (Shia and Lodish, 1989). Lederkremer  and Lodish 
(1990) showed that a human hepatoma cell line (HepG2) ex- 
presses two forms of H2, H2a and H2b, arising by alterna- 
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next to the transmembrane region in the exoplasmic domain. 
H2b, which lacks the five amino acids, accounts for >90% 
of  H2 RNA. In fibroblasts expressing either H2 subunit alone, 
20-40%  of H2b, but no H2a, reaches the cell surface. The 
remainder is degraded. Here we demonstrate a N-tosyi-L- 
lysine  chloromethyl  ketone  (TLCK)-  and  N-tosyl-L-phe- 
nylalanine  chloromethyl  ketone (TPCK)-sensitive  proteolytic 
step initiating the degradation. No degradation of precursor 
H2a or H2b occurs in the presence of these protease inhibi- 
tors, but also there is no increase in the amount of H2b that 
reaches the Golgi region, as compared to untreated cells, in- 
dicating an early, irreversible differential tagging or sorting 
of proteins destined for degradation and proteins destined for 
transport. 
Importantly, Amara et al. (1989) found that, concomitant 
with the disappearance of precursor H2a, small amounts of 
a  soluble 35-kD polypeptide could be detected. The frag- 
ment contains the COOH terminus and is a product of an en- 
doproteolytic cleavage near the five amino acid insertion. 
This fragment could not be detected in the medium. By find- 
ing ways to block the degradation of the fragment without 
affecting the initial cleavage, we were able to accumulate 
sufficient amounts of the intermediat~ degradation product 
to use it as a marker for studying the initial cleavage in the 
degradation process. By localizing the 35-kD intermediate 
to the rough ER,  where the intact precursor  H2b  is also 
found, we established that the TLCK- and TPCK-sensitive 
endoproteolytic cleavage must take place in that organelle. 
Materials and Methods 
Materials 
Materials  were  obtained  from  the  following  sources:  L-[35Slcysteine 
(specific radioactivity of >1,000 Ci/mmole) from ICN Radiochemicals (Ir- 
vine,  CA);  D-[2-3H(N)]-mannose  (specific  radioactivity  30  Ci/mmole) 
from New England Nuclear Du Pont Products (Boston, MA);  ~4C-meth- 
ylated protein standards from Amersham Corp. (Arlington Heights, IL); 
Affigel-protein  A from Bio-Rad (Richmond, CA); cycloheximide, anisomy- 
cin,  emetine, 2,4-dinitrophenol, aprotinin,  chymostatin, PMSE p-nitro- 
phenyl-/3-D-galactopyranoside,  p-nitrophenyl-t~-D-glucoside, and 3-methyl 
adenine from Sigma Chemical Co.  (St.  Louis,  MO);  c~2-macroglobulin, 
bestatin,  N-(N-[L-3-trans-carboxyoxiran-2-carbonyl]-L-leucyl)-agmatine 
(E-64),  leupeptin, pepstatin, TLCK  and TPCK  from Boehringer-Mann- 
helm Biochemicals (Indianapolis, IN); Pronase from Calbiochem-Behring 
Corp. (La Jolla, CA); bicinchoninic acid protein assay reagent from Pierce 
Chemical Co. (Rockford, IL); calf serum, FCS, MEM, DME, glutamine, 
and penicillin/streptomycin from Gibco Laboratories (Grand Island, NY); 
cysteine-free media from Hazelton Products (Denver, PA); tissue culture 
dishes from Costar (Cambridge, MA) and Falcon Labware (Oxnard, CA). 
Cell Culture 
NIH 3T3 fibroblasts cell lines l-7-1, expressing H1 and H2b; 2-18, express- 
ing H2a (Shia and Lodish, 1989);  and 2C, expressing H2b (Lederkremer 
and Lodish, 1990) were grown in DME supplemented with glutamine, pen- 
icillin,  streptomycin, and  10%  calf serum under an atmosphere of 5% 
CO2.  HepG2 ceils were grown in MEM with glutamine, penicillin, strep- 
tomycin, and 10% FCS. The cell monolayers were trypsinized and split into 
35-,  60-,  or  100-mm tissue culture dishes at  least 2  d  before use.  The 
medium for cells incubated at 18"C outside the incubator was supplemented 
with 20 mM Hepes, pH 7.2. 
Metabolic Labeling 
Subconfluent cell monolayers were rinsed twice in medium devoid of cys- 
teine but supplemented with  10%  dialyzed serum, glutamine, penicillin, 
and streptomycin and preincubated for 30 min in this medium. The cells 
were labeled with [asS]cysteine  (200-600/~Ci/ml)  for various lengths of 
time at 37°C. After the pulse, the plates were washed three times with cold 
PBS and transferred to ice, or with 37°C medium containing cysteine and 
returned to the incubator for different chase periods in cysteine-containing 
medium. 
Immunoprecipitation and Electrophoresis 
Cells were lysed in PBS containing 1% Triton X  100/0.5%  sodium deoxy- 
cholate/10 mM EDTA/2 mM PMSF (lysis buffer) for 1 h on ice, and debris 
and nuclei were pelleted in a microfuge for 20 min at 4°C. An aliquot of 
the supernatant, referred to as the cell extract, was spotted on Whatman 
filter paper circles for TCA precipitation, and another aliquot was used for 
determining the protein concentration, using the bicinchoninic acid kit with 
BSA as standard. For experiments involving only a short chase (<3 h) the 
same amount of acid precipitable radioactivity, found to be equivalent to 
the amount of total protein, was immunoprecipitated. For immunoprecipi- 
tation of samples that had been subjected to longer chase periods, the same 
amount of protein was used for each sample, typically 150 ~g, and the vol- 
ume was adjusted to 150 ~1 with lysis buffer. The samples were precleared 
by incubating them on ice for 1 h with 2 ~tl normal rabbit serum and then 
adding 12 p,l of a 25%  Afligel-protein A slurry per p,1 of serum, rotating 
the samples for 30 min in 4°C, and pelleting the beads 20 s in a microfuge. 
The supernatant was incubated with 3 #1 antiserum per 100/zg of protein 
at 0°C overnight. The samples were then incubated with Afligel-Protein A 
as above, and the beads were washed and processed for SDS-PAGE analysis 
on a  10% gel under reducing conditions and fluorography as described in 
Bischoffand Lodish (1987) The antisera used were: H2 COOH antibodies, 
raised against a peptide of the 12 most COOH-terminal amino acids of H2, 
and HI COOH antibodies, raised against a peptide of the 15 most COOH- 
terminal amino acids of ill (Bischoff  et al., 1988) and were kindly provided 
by Drs. Bischoff and Shia (Whitehead Institute, Cambridge, MA). 
Subcellular Fractionation on Sucrose/DzO Gradients 
HepG2 cells grown on  100-mm plates were metabolically labeled as de- 
scribed, rinsed with PBS, and scraped off in 10 mM Hepes, pH 7.2, 0.25  M 
sucrose. After 10 min on ice, the cells were homogenized with 10 strokes 
of a tight-fiRing  Dounce homogenizer. Intact cells and nuclei were spun 
down (centrifuge model  RC-3B;  Sorvall  Instruments,  Newton,  CT)  for 
10 min at 1,000 rpm and the supernatant was loaded on a preformed sucrose 
gradient consisting of 1 ml each of 10,  15, 20, 25, 30, 34, 38, 42, 46,  and 
50%  sucrose in D20 with 10 mM Hepes, pH 7.2.  The gradient was cen- 
trifugated for 3 h (rotor model SW 41;  Beckman Instruments, Polo Alto, 
CA) at 36,000  rpm and 4°C, and fractions were collected from the top. An 
aliquot from each fraction was mixed with an equal volume of two-times 
concentrated lysis buffer and subjected to immunoprecipitation with anti- 
H2 COOH antibodies. Another aliquot was used for determining c~-glucosi- 
dase activity. 
Separation of  Lysosomes from ER/Golgi Vesicles on 
Percoll Gradients 
HepG2 cells grown on  100-ram  plates were metabolically labeled as de- 
scribed, rinsed with PBS, and scraped off the plate in 10 mM triethanol- 
amine/1  mM EDTA/0.25 mM sucrose. After 20 min on ice, the cells were 
homogenized with a ball bearing stainless steel homogenizer (1.85  ×  10  -3 
in clearance) (Batch and Rothman,  1985).  Intact cells and nuclei were 
pelleted (centrifuge model RC-3B; Sorvall Instruments Div., Newton, CT) 
for 10 rain at 2,000 rpm and the supernatant was loaded on a preformed 
Pereoll gradient consisting of 1 m/each of 5, 10, 15, 20, 25, 30, 35, 40, and 
45 % of a Percoll stock solution (90% Percoll in 10 mM triethanolamine/1 
mM EDTA/0.25  mM sucrose). On the bottom of the gradient was a  l-ml 
cushion of 2.5 M sucrose. The gradient was centrifuged for 1 h in a Beck- 
man SW 41 rotor (model SW41; Beckman Instruments Inc., Polo Alto, CA) 
at 24,500 rpm and 4°C and fractions were collected from the bottom. The 
fractions were subjected to immunoprecipitation as described above, and 
aliquots were taken for determination of/3-galactosidase activity. 
Enzyme Assays 
To determine ~-galactosidase activity, 50 p.l of the gradient fractions were 
mixed with 10 ~1 of 20%  Triton X  100, 20 ~1 of 0.5 M citrate buffer, pH 
3.5, and 2 #1 of 0.2 M p-nitrophenol-/3-D-galactopyranoside. The reaction 
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TPCK block degradation of H2a.  2-18 
cells were pulse labeled  with 35S-cysteine 
for 30 min, washed, and chased for 3 h 
in  nonradioactive  medium  containing 
protease inhibitors. (Lane 1 ) pulse only; 
(lane 2) chase without inhibitor; (lane 3) 
chase with  1 mg/ml 3-methyl adenine; 
(lane 4) chase with 0.2 mg/ml c~2-macro- 
globulin; (lane 5) chase with 0.2 inh. U/ 
ml aprotinin; (lane 6) chase with 50 #g/ 
ml  bestatin;  (lane  7)  chase  with  0.2 
mg/ml ehymostatin; (lane 8) chase with 
1 #g/ml E  64;  (lane 9) chase with 0.4 
mg/ml leupeptin; (lane 10) chase with 1 
#g/ml pepstatin;  (lane 11)  chase with 
100  ttM  TLCK;  (lane 12)  chase with 
20/zM TPCK. Cell extracts were immu- 
noprecipitated with H2 COOH antibod- 
ies and subjected to SDS-PAGE and flu- 
orography. The open arrow indicates the 
precursor form of H2a and the solid ar- 
row the position of the 35-kD intermedi- 
ate degradation product. 
mixture was incubated for 5 h at 37°C, and terminated by adding 1 ml of 
0.2 M Na2CO3; the OD41o was read. 
ceglucosidase  assay was performed essentially according to Michael and 
Kornfeld (1980) by mixing 50/~1 of the gradient fraction with 10 ttl of 10 % 
Triton X 100, 10/zl of  25 mM ofp-nitrophenol-ot-D-glucoside,  10 #1 of 1 M 
phosphate buffer, pH 6.9, and 20 #1 of H20. The reaction mixture was in- 
cubated for 5 h at 37°C, and terminated by adding 1 ml of 0.2 M Na2CO3; 
the OD,  t0 was read. This assay will detect the activities of both c~-glucosi- 
dase I and II, and the activity is completely inhibited by 1-deoxynojirimycin 
(Lodish and Kong, unpublished observation), a specific inhibitor of these 
enzymes (Saunier et al., 1982). 
Oligosaccharide Analysis 
2-18 cells were labeled with 3H-mannose (200/zCi/ml) for 3 h in low glu- 
cose (100 mg/1) medium, solubilized, and immunoprecipitated with H2 
COOH antibodies, and run on an SDS-PAGE,  as described. The bands cor- 
responding  to intact H2a and the 35-kD fragment were excised from the gel. 
The gel pieces were incubated with Pronase and the glycopeptides were 
processed as described by Bischoff  et al. (1986). The free oligosaccharides 
were size fractionated  by HPLC on a Micropax AX-5  column by the method 
of Mellis and Baenziger (1981). Starting at acetonitrile/water 60:40 and in- 
creasing the proportion of water, the oligosaccharides  were eluted and frac- 
tions collected. Aliquots from each fraction were taken for determining the 
radioactivity by liquid scintillation  counting. Standards were prepared from 
CHO cells labeled with 3H-mannose for 3 h, as described by Bischoff et 
al. (1986). 
in  size of H2a  accumulating in TLCK- and TPCK-treated 
cells is not always seen, and we do not know the significance 
of the observation. Preincubation of cells with inhibitors be- 
fore labeling gave similar results but were more difficult to 
interpret, since some of the inhibitors also reduced the level 
of protein biosynthesis. TLCK- or TPCK-treated cells, how- 
ever,  showed  the  same  incorporation  of 3sS-cysteine into 
H2a as did control ceils (data not shown). 3-Methyl adenine, 
a specific inhibitor of autophagy (Seglen and Gordon, 1982) 
did not interfere with H2  degradation (Fig.  1,  lane 3). 
Results 
TLCK and TPCK Block Degradation of H2a 
Fig.  1,  lane 1  shows that in 2-18 cells synthesizing H2a,  a 
pulse label reveals a 43-kD precursor with Endo H-sensitive 
oligosaccharides (Amara et al., 1989).  After a 3-h chase all 
of it has been degraded (Fig. 1, lane 2). Furthermore, of all 
protease inhibitors tested, only TLCK and TPCK block deg- 
radation of the  H2a  precursor  (Fig.  1,  lanes  11  and  12). 
TLCK acts on trypsin and related proteases, and can also in- 
hibit endoproteolytic cleavage by some serine and cysteine 
proteases, whereas TPCK inhibits chymotrypsin and some 
endoproteases, including cysteine proteases. The difference 
Figure 2. TLCK and TPCK do not affect intraceUular transport and 
maturation of HI.  1-7-1 ceils were pulse labeled with 35S-cysteine 
for 30 min, washed, and chased for 2 or 3 h in the absence (lanes 
2 and 5) or presence of 100/~M TLCK (lanes 3 and 6) or 20/xM 
TPCK (lanes 4 and 7). Cell extracts were immunoprecipitated with 
H1  COOH-terminal antibodies and subjected to SDS-PAGE and 
fluorography. The open arrow indicates the H1 precursor and the 
striped arrow the mature form of HI. 
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cycloheximide  on degradation of H2a. 2-18 
cells were pulse labeled with 35S-cysteine 
for 15 rain, washed, and chased in nonradio- 
active medium for the times shown in the 
absence (lanes 1-5) or  presence (lanes 6-10) 
of  0.3 mM cycloheximide,  1  mM 2,4-dinitro- 
phenol, and 5 mM 2-deoxy-n-glucose. Cell 
extracts were immtmoprecipitated with H2 
COOH antibodies and subjected to SDS- 
PAGE analysis and fluorography. The open 
arrow indicates the H2a precursor and the 
solid arrow the 35-kD intermediate degra- 
dation product. Molecular weight standards 
are shown on the right. 
To establish whether the actions of TPCK and TLCK were 
specific or because of toxic effects, we carried out an experi- 
ment in which we followed the intracelltilar transport and 
glycosylation of H1  in drug-treated cells (Fig.  2).  In  1-7-1 
cells, which express both HI and H2b, H1 is synthesized as 
a 40-kD precursor (lane/) and is converted after a 2- or 3-h 
chase to a 46-kD species with Endo H-resistant oligosac- 
charides (Shia and Lodish, 1989) (lanes 2 and 5). TLCK and 
TPCK did not block conversion of  precursor H1 to the 46-kD 
species (lanes 3, 4,  6, and 7). In control 1-7-1 cells, conver- 
sion of precursor HI to the mature species is not quantita- 
tive; about half of the precursor is degraded. In TLCK- or 
TPCK-treated cells, the H1 that would have been degraded 
is recovered as the 40-kD precursor (lanes 3,  4,  6, and 7). 
Thus, in 1-7-1 cells TLCK and TPCK do not block matura- 
tion of the normal amount of H1 through the Golgi but do 
block degradation of the  ,o50%  of the H1  precursor that 
would normally be destroyed. 
Inhibitors of  Protein Biosynthesis or ATP 
Production Block Further Degradation of the 35-kD 
Degradation Intermediate 
Small amounts of a 35-kD putative degradation intermediate 
can be observed during degradation of H2a in 2-18 cells. The 
fragment is  recognized by H2 COOH-terminal antibodies 
but not by antibodies recognizing a peptide in the NH2-ter- 
minal cytoplasmic domain (Amara et al., 1989). The size of 
the fragment corresponds to that of the exoplasmic domain 
of H2a, which suggests that it is the product of an endopro- 
teolytic cleavage near the five amino acids that differentiate 
H2a from H2b. Since a degradation intermediate would be 
an important tool for localizing the degradation process, we 
set out to block selectively subsequent steps of degradation. 
Disappearance of the 35-kD fragment was followed as the 
loss of reactivity in the 35-kD fragment, using the H2 COOH 
antibody. 
Lanes 1-5 in Fig. 3 show the time course of degradation 
of H2a precursor in untreated 2-18 cells. Small amounts of 
a 35-kD intermediate could be detected after a 45-min chase 
period (lane 2), and by 180 min of chase (lane 5), all precur- 
sor H2a and 35-kD fragment had disappeared. If cyclohexi- 
mide, 2,4-dinitrophenol, and 2-deoxy-D-glucose are added 
to the chase medium, all pulse-labeled H2a precursor is con- 
verted to a 35-kD fragment (lanes 7-10). As before, the 35- 
kD fragment is immunoprecipitable with the H2 COOH an- 
tibody, but not with an NH2-terminal antibody (Amara et 
al., 1989). Therefore, we conclude that the cleavage is endo- 
proteolytic. Conversion of H2a to the 35-kD intermediate in 
cells containing cycloheximide, 2,4-dinitrophenol and 2-de- 
oxy-D-glucose is quantitative, considering the loss of three 
cysteines because of endoproteolysis: the H2a precursor has 
11  cysteine residues  (Spiess  and  l.xxtish,  1985),  and  the 
35-kD fragment probably eight. 
Fig. 4 shows that conversion of precursor H2a (lane/) to 
the 35-kD fragment during a 3-h chase is less complete when 
2,4-dinitrophenol and 2-deoxy-D-glucose (lane 3) and cyclo- 
heximide (lane 4) are added separately than when they are 
Figure 4. Inhibitors of ATP production or protein synthesis block 
degradation of the 35-kD intermediate fragment. 2-18 cells were 
pulse labeled with 35S-cysteine  for 30 min (lane 1); washed and 
chased for 3 h in nonradioactive medium without drugs (lane 2); 
or  containing  1 mM  2,4-dinitrophenol  and  5  mM  2-deoxy-o- 
glucose (lane 3); 0.3 mM cycloheximide  (lane 4); 0.5/~M anisomy- 
cin (lane 5); or 0.5/zM emetine (lane 6). The cell extracts were 
immunoprecipitated with H2 COOH antibodies and subjected to 
SDS-PAGE and fluorography. The open arrow indicates the H2a 
precursor and the solid arrow the 35-kD intermediate degradation 
product. 
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D-glucose and TPCK on the intracellular fate of H2b. 2C cells were 
pulse labeled with 3~S-cysteine  for 30 min, washed, and chased in 
nonradioactive medium for 3 h under  the following conditions: 
(lane 2) without drugs; (lane 3) in the presence of 20/zM TPCK; 
(lane 4) in the presence of 1 mM 2,4-dinitrophenol and 5 mM 
2-deoxy-D-glucose;  and (lane 5) in the presence of 0.3 mM cyclo- 
heximide. Lane I represents the pulse-labeled sample. The cell ex- 
tracts were immunoprecipitated with H2 COOH antibodies, and 
subjected to SDS-PAGE and fluorography. The open arrow indi- 
cates precursor H2b, the solid arrow the 35-kD intermediate degra- 
dation product, and the striped arrow the mature form of H2b. 
added together (compare with Fig. 3). Anisomycin and eme- 
tine (lanes 5 and 6) have the same effect as cycloheximide. 
The concentrations of these drugs  are sufficient to inhibit 
completely protein biosynthesis in 3T3 fibroblasts (data not 
shown). 
Precursor H2b Is Degraded by the Same Pathway as 
H2a When Expressed Alone in b~broblasts or Together 
with H1 in HepG2 Cells 
Lederkremer and Lodish (1990) showed that between 20 and 
40% of H2b reaches the cell surface when expressed alone 
in  fibroblasts (2C  cells).  What happens  to the  remaining 
H2b? Is it degraded by the same pathway as H2a, or are the 
extra five amino acids in H2a a target sequence for an en- 
doprotease or signal  for sorting to a  putative degradation 
compartment? In an attempt to approach these questions we 
conducted a  pulse-chase experiment in  2C  cells (Fig.  5) 
using the inhibitors we found useful in studying degradation 
of H2a. A pulse label (lane/) reveals the 43-kD H2b precur- 
sor.  After a  3-h  chase  in  the  absence  of drugs  (lane 2), 
roughly equal amounts  of the precursor,  a  mature 50-kD 
form and the 35-kD intermediate are seen. If TPCK is pres- 
ent during the chase  (lane 3),  the amount of mature H2b 
roughly equals that of the control cells (lane 2), indicating 
that TPCK does not interfere with transport and maturation 
of H2b.  Importantly,  more precursor is  found in  TPCK- 
treated cells, consistent with TPCK inhibition of the initial 
endoproteolysis of I-I2a (Fig. 1). For unknown reasons, some 
of the  35-kD  fragment  is  also  formed.  Addition  of 2,4- 
dinitrophenol and 2-deoxy-D-glucose to the chase medium 
(Fig.  5, lane 4), partially blocks degradation of the 35-kD 
fragment;  ER-to-Golgi transport of H2b is  also reduced, 
resulting in an increased level of H2b precursor, and a de- 
crease in the level of  mature protein. In the presence of  cyclo- 
heximide (Fig. 5, lane 5), the level of mature H2b is com- 
parable  to  that  of  the  control,  indicating  no  effect  of 
cycloheximide on  ER-to-Golgi transport.  Importantly,  no 
precursor can be detected;  instead  virtually all precursor 
H2b has been converted to the 35-kD fragment. Thus, in the 
presence of cycloheximide, the remaining portion of H2b 
that would be degraded during a 3-h chase (compare lanes 
1 and 2) is converted to the 35-kD intermediate. We con- 
clude that 20--40% of precursor H2b in 2C cells will move 
from the ER to the Golgi in the absence (Fig. 5, lane 2) or 
presence of drugs (lanes 3 and 5). Apparently some segrega- 
tion occurs early after biosynthesis between H2b molecules 
destined for Golgi transport and those that will be degraded; 
the fraction destined for degradation does not mature to the 
Golgi if degradation is blocked by TPCK. 
The reason for the slight difference  in mobility between the 
fragment generated in cycloheximide-treated cells (lane 4) 
and in 2,4-dinitrophenol-treated cells (lane 5) is probably 
because of differences in carbohydrate processing. The 35- 
kD fragment is in both cases resistant to cleavage by Endo 
D, but after digestion with Endo H the size of both fragments 
appears to be the same (data not shown). A similar size dif- 
ference of the 35-kD fragments is seen in HepG2 ceils (see 
Fig. 7, lanes B3 and B4). The 35-kD fragment derived from 
H2b  is  recognized by  H2  COOH  antibodies,  but  not  by 
NH2-terminal  antibodies  (data  not  shown),  suggesting  a 
similar origin for the 35-kD H2b fragment as for the 35-kD 
H2a fragment. Thus the extra five amino acids in H2a do not 
constitute an obligatory degradation signal; rather H2b can 
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Figure 6. Degradation of the 35-kD intermediate forms of H2a and 
H2b. 2-18 (o) and 2C (e) cells were pulse labeled with 35S-cystcinc 
for 30 rain and chased  in nonradioactive medium for 3 h in the pres- 
ence of 0.3 mM cyclohcximide. The cycloheximide was removed 
and  the  incubation  continued in  the  absence  of  drugs for  the  indi- 
cated  periods of  time.  The cell  extracts  were immunoprecipitated 
with  142  COOH  antibodies  and  the  samples subjected  to  SDS-PAGE 
analysis  and fluorography.  The bands on the autoradiogram were 
quantitated by densitometric scanning and normalized to the amount 
present at 0 rain. 
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dinitrophenol, 2-deoxy-D-glucose,  cycloheximide, anisomycin, eme- 
tine,  TPCK, and  TLCK.  HepG2 ceils  were  pulse  labeled  with 
35S-cysteine for 30 min (lanes A/and B1 ) and chased in nonradio- 
active medium for 4 h in the absence (lanes A2 and B2) or pres- 
ence of 1 mM 2,4-dinitrophenol  and  5  mM 2-deoxy-D-glucose 
(lanes A3 and B3); 0.3 mM cycloheximide (lanes A4 and B4); 0.5 
/~M anisomycin (lanes A5 and B5); 0.5/zM  emetine (lanes A6 and 
B6); 100 #M TLCK (lanes A7 and//7);  or 20 #M TPCK (lanes 
A8 and B8). One half of each sample was immunoprecipitated with 
H1 COOH antibodies (A) and the other half with H2 COOH anti- 
bodies (B) and then the samples were subjected to SDS-PAGE  anal- 
ysis and fluorography. The open arrow indicates precursor H1 or 
H2, the solid arrow the 35-kD intermediate degradation product of 
H2, and the striped arrow indicates the mature forms of HI or H2. 
be degraded by a mechanism that shows the same inhibitor 
sensitivity as does H2a. 
To obtain information on the kinetics of degradation of the 
35-kD fragment, we designed the following experiment (Fig. 
6):  2-18  (expressing  H2a)  and 2C  (expressing  H2b)  cells 
were pulse labeled for 30 min and chased for 3 h in the pres- 
ence of cycloheximide to accumulate the 35-kD fragment. At 
zero minutes on the figure, the drug was removed and the in- 
cubation continued.  The relative amounts of H2a and H2b 
were quantified by densitometric scanning of the autoradio- 
gram. Disappearance of the 35-kD fragment generated from 
H2a  (open circles) and  H2b  (closed  circles) occur  with 
roughly similar kinetics. The half-life of H2a is •90  min and 
the H2b 35-kD fragment is degraded slower than that from 
H2a. 
Studies by Bischoff and Lodish (1987) show that in HepG2 
cells only about two thirds of newly synthesized H1 and H2 
subunits reach the cell surface; a third is degraded. (As noted, 
>90%  of H2  in  HepG2 cells  is  H2b,  as judged  by RNA 
quantification).  We wanted to study H2 degradation in this 
more normal system, where H2 is expressed together with 
HI. To this end,  HepG2 cells were pulse labeled and then 
chased in the presence or absence of drugs (Fig.  7).  Lanes 
A/and B1 show the pulse-labeled precursor forms of H1 and 
H2,  respectively, and the  mature forms,  generated  in  un- 
treated cells after a 4-h chase are seen in lanes A2 and B2. 
Cells treated with inhibitors  of protein biosynthesis (lanes 
A4, A5, and A6) or TLCK and TPCK (lanes A7and A8) show 
the same level of mature HI as control (lane A2), again show- 
ing that these inhibitors have no effect on intracellular matu- 
ration of HI. In cells treated with cycloheximide (lane A4), 
anisomycin (lane AS), emetine (lane A6), and to some extent 
TLCK (lane A7),  some precursor protein (open arrow) can 
still be detected.  The effect of 2,4-dinitrophenol  and 2-de- 
oxy-D-glucose (Fig. 7, lane A3), a lower level of mature pro- 
tein and an increased level of precursor HI, can be attributed 
mainly to inhibited  ER-to-Golgi transport. 
Similarly, the level of Golgi-processed mature H2 is not 
affected by inhibitors of protein biosynthesis (lanes B4, B5, 
and B6) or TLCK or TPCK (lanes B7 and B8). 2,4-Dinitro- 
phenol and 2-deoxy-D-glucose (Fig.  7, lane B3), cyclohexi- 
mide (lane B4), anisomycin (lane B5), and emetine (lane B6) 
all cause accumulation of the 35-kD intermediate (solid ar- 
row). That is, the fraction of precursor H2 that is degraded 
in control cells (lane B2) is converted to a 35-kD intermedi- 
ate by the same treatments that in 2C cells cause all precursor 
H2b to be converted into the 35-kD intermediate fragment 
(Fig. 5).  Cells treated with 2,4-dinitrophenol and 2-deoxy- 
D-glucose (Fig. 7, lane 3) do accumulate some H2 precursor 
protein and show reduced levels of mature H2, probably be- 
cause  of inhibition  of intracellular  transport  of H2.  The 
effects of TLCK and TPCK on degradation of HI and espe- 
cially H2 in HepG2 cells are not as strong as in 2-18 or 2C 
fibroblasts. We do not know why.  One possibility is that the 
drugs cannot enter into HepG2 cells as easily. 
Oligosaccharide Analyses of Precursor H2a and the 
35-kD Fragment Indicate a Pre-Golgi Localization 
The subcellular localization of the 35-kD intermediate in H2 
degradation  need  not  be  the  same  as  the  site  of the  ini- 
tial TLCK- and TPCK-sensitive endoproteolytic degradation 
that  generates  it,  nor the  site of its  ultimate degradation. 
However, since we can show, by several criteria, that the 35- 
kD fragment is in the ER, it would appear that at least the 
initial stage of degradation occurs in that organelle. 
Determining the composition of oligosaccharides on gly- 
coproteins is a  widely used method to obtain information 
about the compartment in which a protein destined for trans- 
port  is  residing  (for  review  see  Kornfeld  and  Kornfeld, 
1985).  We know that  the  three  N-linked glycans on both 
precursor H2a and the 35-kD fragment are resistant to cleav- 
age by Endo D, but sensitive to Endo H (Amara et al., 1989). 
To  obtain  more  detailed  information  about  them,  HPLC 
analysis was performed on the glycans from H2a and the 35- 
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Figure 8. Only high mannose oligosaccharides are seen on precursor H2a and the 35-kD intermediate degradation product. 2-18 cells were 
labeled with D-[2-3H(N)]-mannose for 3 h in low glucose medium, immunoprecipitated with H2 COOH antibodies, and analyzed by 
SDS-PAGE. The bands corresponding to H2a and the 35-kD fragment were recovered from the gel. The oligosaccharides from H2a (A) 
and the 35-kD fragment (B) were released, purified, and size fractionated by HPLC on a Micropax AX-5 column. The collected fractions 
were analyzed for radioactivity by liquid scintillation counting. Standards were prepared according to Bischoff et al. (1986). Positions of 
MansGlcNAc to MangGIcNAc are designated by ms to m9. 
kD fragment (Fig. 8). Fig. 8 A shows that the H2a precursor 
has  mainly MangGlcNAc2  and  MansGlcNac2  oligosaccha- 
rides, and so does the 35-kD fragment (Fig. 8 B), which also 
contains substantial amounts of Man6GtcNAc2.  No signifi- 
cant amounts  of MansGlcNAc2  can be detected on either 
H2a or the 35-kD fragment. The enzyme responsible for 
catalyzing the  formation of MansGlcNAc2,  Golgi-ct-man- 
nosidase 1, is thought to reside in the cis-Golgi (Kornfeld  and 
Kornfeld, 1985), and the lack of MansGlcNAc2  on H2a and 
the 35-kD intermediate indicates that neither of the mole- 
cules has reached the Golgi complex. We do not know the 
identity of the single-fraction peaks seen between MansGlc- 
NAc  and  MangGlcNAc  and  between  MansGlcNAc  and 
Man6GlcNac. They do not arise by readdition of  glucose resi- 
dues as has been seen for some ER-localized proteins (Suh 
et al.,  1989),  since they are completely digested by Jack 
Bean c~-mannosidase  (J. Bischoff, personal communication). 
The 35-kD Fragment is Absent  from Lysosomes and 
Localized to the Rough ER 
Previous  evidence  against  participation  of lysosomes  in 
degradation from the ER comes from experiments showing 
absence of inhibition by lysosomotropic agents or inhibitors 
of lysosomal proteases, and also showing absence of any in- 
tact precursor protein in lysosomes. By showing (Fig. 9) that 
the 35-kD fragment is not in lysosomes, we can eliminate 
this organeUe as the site of the initial endoproteolytic cleav- 
age.  In this  experiment we separate lysosomes from ER/ 
Golgi vesicles on Percoll gradients.  These studies, as well 
as separations using D20/sucrose gradients  (below),  were 
done on HepG2 cells, not on transfected fibroblasts, since 
preliminary fractionation of fibroblasts did not cleanly re- 
solve lysosomes, rough ER, and Golgi (not shown). 
HepG2 cells were pulse labeled with radioactive cysteine 
for 15 min (Fig. 9 A), or 30 min followed by a 4-h chase in 
the presence of cycloheximide, to convert about one third of 
the H2 precursor to the 35-kD fragment (Fig. 9 B). We used 
labeled transferrin as a reference ER protein, as it exits the 
ER slowly; after a pulse or chase virtually all labeled trans- 
ferrin in the cell is in the ER (Lodish et al.,  1983). In both 
gradients  between 55  and  65%  of the lysosomal enzyme 
/~-galactosidase was detected in the three bottom fractions, 
whereas virtually all 43-kD precursor H2  and transferrin 
(Fig. 9 A) and all mature H2 and intermediate 35-kD frag- 
ment (Fig. 9 B) was localized to the middle fractions of the 
gradient. We conclude that the initial endoproteolytic degra- 
dation step does not occur in lysosomes. 
In an attempt to localize further the compartment in which 
the intermediate degradation product accumulates, we turned 
to subcellular fractionation on D20/sucrose gradients (Lod- 
ish et al., 1983, 1987). HepG2 cells were pulse labeled (Fig. 
10 A) or chased for 4 h in the presence of  cycloheximide  (Fig. 
10, B and C).  Following the protocol of Lodish and Kong 
(1990) the postnuclear supernatant loaded on the gradient 
shown in Fig.  10 C was pretreated with EDTA and RNase 
to strip off ribosomes and decrease the density of the rough 
ER. In this study, c~-glucosidase activity was used as a mark- 
er for the ER, since t~-glucosidases I and II reside in the ER 
and act on ER-localized substrates (Hubbard and Robbins, 
1979; Kornfeld and Kornfeld, 1985; Lucocq et al.,  1986). 
Similar results were obtained using Endo H-sensitive trans- 
ferrin precursor as an ER marker (not shown). After a pulse 
(Fig.  10 A),  ~glucosidase  activity and precursor H2 are 
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Figure 9. H2 and the 35-kD inter- 
mediate degradation product do 
not cofractionate with lysosomes. 
HepG2  cells were labeled  with 
35S-cysteine  for 15 min (A) or 30 
min followed  by a 4-h chase in the 
presence of  0.3 mM cycloheximide 
(B). The cells were homogenized, 
and the postnuclear supernatants 
were loaded on 5--45  % preformed 
Percoll gradients with cushions of 
2.5 M sucrose. After 1 h of cen- 
trifugation  (rotor model  SW41; 
Beckman Instruments) at 24,500 
rpm, 10 fractions were collected, 
assayed for fl-galactosidase activ- 
ity, and immunoprecipitated with 
antibodies against H2 COOH and 
transferrin. The immunoprecipi- 
tated material was separated by 
SDS-PAGE and subjected to fluo- 
rography. The  quantification of 
precursor and mature H2, the 35- 
kD H2 fragment, and precursor 
and mature transferrin was done 
by densitometric scanning of the 
autoradiograms, and normalized 
to the total amount recovered in 
all fractions. 
found mainly in fractions 7-10 (21-31%  sucrose), defining 
the ER. After a 4-h chase in the presence of cycloheximide 
(Fig.  10 B), a portion of H2 has reached the Golgi and ac- 
quired complex glycans. It bands in a less dense region, frac- 
tions 3-5 (Fig.  10 B, indicated by arrows), that correspond 
to the density of Golgi and plasma membranes. Importantly, 
a portion of H2 has been converted to the 35-kD intermedi- 
ate, and virtually all bands in fractions 7-10 coincident with 
ER a-glucosidase. Upon EDTA and RNAse treatment (Fig. 
10 C), vesicles containing both the 35-kD intermediate and 
ct-glucosidase  activity  band  at  a  slightly  lighter  density 
(mainly fractions 5-7 [16-23 % sucrose]). The mature H2 in 
the Golgi still bands in fractions 3-5. We conclude that the 
density of vesicles containing the 35-kD degradation inter- 
mediate is indistingu.shable from that of  an authentic ER pro- 
tein (a-glucosidase) as well as that of transferrin precursors, 
both with and without removal of ribosomes by RNAse and 
EDTA.  Thus, the 35-kD intermediate resides in a part of 
the ER that contains ribosomes, and the initial endoproteo- 
lyric cleavage that generates it must also be localized to that 
organelle. 
Discussion 
Our data suggests that degradation of H2a occurs in at least 
two distinct steps. First, the intact H2a molecule is clipped 
by an endoprotease, generating a 35-kD fragment. Judging 
from the size of the fragment and its reactivity with antibod- 
ies, the clip occurs on the exoplasmic side of the transmem- 
brane domain. The 35-kD fragment is probably soluble, and 
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Figure 10.  The  35-kD fragment  is  localized in the  rough ER. 
HepG2 cells were labeled with 35S-cysteine  for 15 min (A) or 30 
min followed by a 4-h chase in the presence of 0.3 mM cyclohexi- 
mide (B and C). The cells were homogenized and the postnuclear 
supernatants were loaded on preformed 10-50% sucrose/D20 gra- 
dients. The postnuclear supernatant that was loaded on the gradient 
shown in C was pretreated with 15 mM EDTA and 200/~g/ml of 
RNase for 10 min on ice. After 3 h of centrifugation (rotor model 
SW41; Beckman Instruments) at 36,000 rpm fractions were col- 
lected.  The fractions  were solubilized and  immunoprecipitated 
with antibodies to H2 COOH, and an aliquot was used to determine 
c~-glucosidase  activity. The immunoprecipitated material was sepa- 
rated by SDS-PAGE  and subjected to fluorography. The quantifica- 
tion of precursor and mature H2 and the 35-kD fragment was done 
by densitometric scanning of the autoradiograms. Fractions con- 
taining mature H2 are indicated with arrows. 
since the size of the fragment is slightly different for H2a and 
H2b (Fig. 6), we believe that the clip occurs NH2-terminal 
to the extra five amino acids in H2a. The initial endoproteo- 
lyric cleavage is inhibited by protease inhibitors TLCK and 
TPCK (Figs.  1, 2,  and 5).  These drugs probably stabilize 
precursor H2a and H2b by inhibiting the endoprotease that 
would otherwise initiate the degradation process. Since nei- 
ther TLCK nor TPCK inhibit protein biosynthesis, ER-to- 
Golgi transport, or processing of glycans (Figs. 2, 5, and 7), 
their effect on H2 degradation is specific and indicates par- 
ticipation of a TLCK- and TPCK-sensirive protease. This 
initial endoproteolytic clip is not sensitive to inhibitors of 
protein biosynthesis or to ATP depletion, but these  sub- 
stances inhibit degradation of the 35-kD intermediate frag- 
ment (Figs.  3-5,  and 7). 
The 35-kD fragment does not accumulate in lysosomes, 
as judged by subcellular fractionation (Fig. 9), eliminating 
a role for lysosomes in at least the initial endoproteolytic, 
TLCK- and TPCK-sensitive step of  H2 degradation. Further, 
subcellular fractionation shows that the 35-kD fragment ac- 
cumulates in a membrane compartment which has the density 
of  the rough ER, and contains ribosomes (Fig. 10). Oligosac- 
charide analysis confirms the localization in the ER by reveal- 
ing a composition of the N-linked oligosaccharides on the 
35-kD fragment that is typical of proteins with a pre-Golgi 
localization (Fig. 8). The 35-kD fragment is not localized to 
an ER-to-Golgi transport vesicle, since in HepG2 cells the 
density of these is lighter than that of the Golgi (Lodish et 
at., 1987) while the compartment containing the 35-kD frag- 
ment has the much heavier density of  the rough ER (Fig. 10). 
We conclude that the initial TPCK and TLCK-sensitive  cleav- 
age of H2 occurs in the rough ER. However, our data is also 
consistent with the notion that the  fragment is formed in 
some ER-to-Golgiintermediate  compartment (Pelham, 1988) 
and recycled back to the ER. 
Proteolytic clipping  of several viral glycoproteins have 
been reported, of which the VSV G protein is perhaps the 
most extensively characterized. The precursor ts045 G pro- 
tein accumulates in the rough ER membrane and a soluble 
fragment,  G~,  is  generated in  the ER or other pre-Golgi 
compartment and is subsequently released into the medium 
(Garreis-Wabnitz  and  Kruppa,  1984;  Chen  and  Huang, 
1986). It would be of  interest to see whether TPCK or TLCK 
block generation of Gs. 
Since the transmembrane domain in H2 serves as a non- 
cleavable signal sequence, Amara et al. (1989) proposed that 
the ER protease signal peptidase might generate the 35-kD 
fragment. We tested this hypothesis by metabolically label- 
ing fibroblasts expressing recombinant human albumin  (a 
nonglycosylated  protein) in the presence of TLCK or TPCK. 
There was no difference in the size of albumin compared to 
untreated ceils, indicating that signal sequence cleavage oc- 
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Thus, the participation of signal peptidase in H2 degradation 
is unlikely. 
The finding that both H2a and H2b are degraded by very 
similar pathways is interesting, but the role of the five amino 
acids (the sole difference between the two forms of H2) in 
the degradation remains an open question; they probably do 
not act as signal for targeting H2 to a putative degradation 
compartment or function as a target sequence for an endo- 
protease. 
For two other proteins which are subject to ER degrada- 
tion, the transmembrane domain is the determinant for rapid 
and selective degradation. The basal turn-over of 3-hydroxy- 
3-methylglutaryl  coenzyme A  (HMG  CoA)  reductase,  a 
monomeric  ER-resident  protein  with  a  highly  regulated 
degradation  pattern  (reviewed by  Goldstein  and  Brown, 
1990), is inhibitable by lysosomotropic agents, whereas the 
rapid, inducible degradation is not (Tanaka et al.,  1986). A 
fusion protein consisting of the membrane spanning,  non- 
catalytic part of HMG CoA reductase and B-galactosidase is 
localized to the ER (Skalnik et al.,  1988). The ~-galactosi- 
dase activity is as sensitive to rapid degradation induced by 
sterols as is intact HMG CoA reductase. Also, deletions of 
single amino acids in the membrane-spanning domain of the 
chimeric molecule results in abolition of  sterol-inducible deg- 
radation of B-galactosidase, while the localization of the fu- 
sion protein is unaffected. Bonifacino et al. (1990) identified 
the transmembrane domain of TCR ~x chain as a determinant 
for the ER degradation; a normally stable cell surface pro- 
tein, the Tac antigen, becomes a target for ER degradation 
when its transmembrane domain is substituted with that of 
the TCR ~x chain. 
Considering our data on the degradation of H2 in light of 
these results, we believe that precursor H2 folding or oligo- 
merization prevents ER degradation. H2a in 2-18 cells might 
be unable to oligomerize, and as a  result all is  degraded; 
when coexpressed with HI, some H2a is stabilized by form- 
ing oligomers and is transported to the cell surface (Leder- 
kremer and Lodish, 1990). Some H2b in 2C cells and HepG2 
cells do form oligomers and mature to the Golgi and are pro- 
tected from degradation. Wileman et al. (1990) and Bonifa- 
cino et al. (1989) showed that rapidly degraded TCR subunits 
can be stabilized by coexpressing them with degradation- 
resistant chains. 
Oligomerization is  a  prerequisite for transport of many 
proteins out of the ER (Kreis and Lodish,  1986; Copeland 
et al.,  1986; Gething et al.,  1986).  Our results show that 
even if degradation was prevented by TLCK or TPCK, the 
amount of H1 and H2b transported out of the ER was not in- 
creased (Figs. 2, 5, and 7) leading us to believe that the rest 
of the H2 molecules cannot leave the ER even if they are not 
degraded. In the presence of TLCK or TPCK H2a in 2-18 
cells  does  not  acquire  complex carbohydrate side  chains 
(Fig.  1),  again  suggesting  that  none is  transported to the 
Golgi. These results suggest that there is an early sorting or 
tagging of proteins destined for degradation and proteins 
destined for transport to the Golgi, and that once a protein 
has been selected for degradation the decision is irreversible, 
even if degradation is blocked. Evidence suggesting sorting 
within the ER of proteins destined for degradation was ob- 
tained by Chen et al. (1988), who studied the fate of  the TCR 
e, % and ~ subunits (the CD3 complex) in a T cell hybridoma 
deficient in expression of the ~ subunit. The ~5 chain is de- 
graded by the ER pathway and the e and 3' chains are stable. 
Failure of the  ~-3'  complex to be co-immunoprecipitated 
with antibodies to the 5 chain led them to conclude that deg- 
radation of ~5 occurs in a compartment different from that of 
receptor synthesis and assembly (presumably the rough ER), 
otherwise the e-7 complex would have access to newly made 
chain and coprecipitate. 
Inhibitors of protein biosynthesis and energy production 
block degradation of the 35-kD H2 degradation intermedi- 
ate.  Reportedly, they have no effect on degradation of the 
TCR a  chain (Lippincott-Schwartz et al.,  1988). However, 
no degradation intermediate has been detected for the TCR 
c~ chain. 
Cycloheximide is often used as an inhibitor of lysosomal 
degradation.  However,  Amara  et  al.  (1989)  showed  that 
lysosomotropic agents do not affect degradation of H2a, and 
our results reveal that the 35-kD fragment is not in lyso- 
somes, indicating no role for lysosomes in at least the initial 
endoproteolytie step of H2 degradation. Inhibition of degra- 
dation of the 35-kD intermediate by cycloheximide and other 
inhibitors of  protein biosynthesis could indicate that this sec- 
ond degradation step involves an unstable protease, a point 
that  remains  to  be  investigated.  Energy  inhibitors  could 
block the same step as does cycloheximide  by inhibiting pro- 
tein synthesis. Other possibilities are that an ATP-dependent 
protease is involved, or that a membrane transport step is 
required.  Dunn  (1990)  showed  that  autophagosomes  are 
formed from ribosome-free regions of the ER, but there are 
no  indications  that  autophagy  would  account for the  ER 
degradation of H2. In particular, 3-methyl adenine, an inhib- 
itor of autophagy (Seglen and Gordon, 1982), has no effect 
on the degradation of H2 (Fig.  I). 
Thus, while we can state that the initial endoproteolytic 
cleavage in H2 degradation occurs in the rough ER, we do 
not know where the subsequent degradation of the 35-kD in- 
termediate takes place, except that it is probably not in lyso- 
somes. It could also occur in the ER or an ER-related com- 
partment,  near  the  site  of  accumulation  of  the  35-kD 
intermediate. 
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